Trial Profile
A study investigating the efficacy of combination of pravastatin and ezetimibe and its effect on carotid intima-media thickness in systemic lupus erythematosus patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Pravastatin (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- 28 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.